{"database": "lobbying", "table": "lobbying_activities", "rows": [[2326609, "c619529e-95ae-4bc1-b43b-0b4469ecba40", "Q2", "AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY", 1386, "AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY", 2019, "second_quarter", "TOB", "Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies. \n\nCoalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH).\n\nCoalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). \n\nCoalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.\n\nCoalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.\n\nCoalition letter addressed to the Chairman of the House Energy and Commerce Committee expressing support for H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,U.S. Trade Representative (USTR)", null, 250000, 0, 0, "2019-07-22T15:00:44.480000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2326609"], "units": {}, "query_ms": 37.24123409483582, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}